輸入代號或公司名稱後按 Enter
3176

基亞

+1.55 (+4.43%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
36.502,843成交張數本益比3.44股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.19-1.81-0.26-9.1%-1.75%-15.93%
2026Q1-0.38-151.3%-1.90-0.53-20.3%-3.49%-16.62%
2025Q4-0.84-0.78-1.17-35.8%-7.32%-6.95%
2025Q3-0.40-0.76-0.56-14.3%-3.39%-6.38%
2025Q2-0.28-450.0%-0.55-0.38-10.5%-2.25%-4.54%
2025Q10.74-0.191.0220.5%6.27%-1.63%
2024Q4-0.82-1.47-1.14-34.5%-6.99%-12.90%
2024Q3-0.19-2.96-0.27-6.2%-1.61%-23.30%
2024Q20.08-3.110.123.4%0.74%-24.22%
2024Q1-0.54-3.89-0.76-30.1%-4.81%-30.76%
2023Q4-2.31-4.03-3.22-86.8%-18.65%-29.65%
2023Q3-0.34-4.27-0.47-11.3%-2.50%-26.97%
2023Q2-0.70-4.77-0.97-47.3%-5.03%-29.98%
2023Q1-0.68-4.95-0.95-57.6%-4.55%-30.97%
2022Q4-2.55-563.6%-4.86-3.55-174.4%-15.00%-29.46%
2022Q3-0.84-282.6%-1.76-1.16-66.0%-4.59%-10.38%
2022Q2-0.88-0.46-1.23-64.1%-4.91%-2.84%
2022Q1-0.59-0.51-0.82-16.9%-3.35%-3.21%
2021Q40.55-0.380.773.5%3.40%-2.50%
2021Q30.46-1.410.644.6%3.10%-10.95%
2021Q2-0.93-2.66-1.29-73.9%-6.71%-22.40%
2021Q1-0.46-2.38-0.64-34.5%-3.46%-20.37%
2020Q4-0.48-2.43-0.67-35.0%-4.09%-21.28%
2020Q3-0.79-2.96-1.11-71.8%-7.94%-28.08%
2020Q2-0.65-258.5%-2.80-0.90-64.3%-6.65%-26.47%
2020Q1-0.51-1.74-0.70-53.8%-5.17%-16.79%
2019Q4-1.01-1.84-1.41-83.2%-9.86%-17.65%
2019Q3-0.63-2.28-0.87-78.5%-5.63%-19.61%
2019Q20.41-2.370.5734.0%3.65%-19.27%
2019Q1-0.61-3.44-0.85-79.7%-5.55%-28.83%
2018Q4-1.45-3.19-2.02-293.4%-12.34%-26.23%
2018Q3-0.72-2.89-0.99-89.5%-5.57%-21.53%
2018Q2-0.66-2.87-0.91-80.5%-5.05%-20.79%
2018Q1-0.36-2.92-0.50-44.1%-2.78%-20.83%
2017Q4-1.15-3.37-1.59-129.4%-8.32%-23.11%
2017Q3-0.70-3.14-0.97-87.2%-4.88%-20.28%
2017Q2-0.71-3.52-0.98-82.6%-4.79%-22.16%
2017Q1-0.81-4.09-1.12-107.5%-5.22%-24.46%
2016Q4-0.92-4.10-1.28-138.7%-5.67%
2016Q3-1.08-1.49-150.4%-6.35%